Breaking News Instant updates and real-time market news.

OTIC

Otonomy

$3.35

(0.00%)

07:32
08/06/18
08/06
07:32
08/06/18
07:32

Otonomy, Mission Pharmacal sign co-promotion agreement for OTIPRIO

Otonomy announced the signing of a co-promotion agreement with Mission Pharmacal Company that provides Mission with an exclusive right to promote OTIPRIO for acute otitis externa in pediatrician and primary care physician offices as well as urgent care clinics in the United States. Financial terms for the multi-year agreement were not disclosed; however, Otonomy will receive an annual co-promotion fee and reimbursement of a proportion of product support expenses, and retain a share of gross profits from the sale of OTIPRIO to Mission's accounts. Otonomy retains all commercial rights for other customer segments for AOE and use of OTIPRIO in all other indications including ongoing sales for use during pediatric ear tube surgery.

  • 08

    Aug

OTIC Otonomy
$3.35

(0.00%)

08/30/17
08/30/17
DOWNGRADE
Target $8

Neutral
Otonomy downgraded to Neutral after trial failure at Piper Jaffray
As previously reported, Piper Jaffray analyst Charles Duncan downgraded Otonomy to Neutral from Overweight and cut his price target on the stock to $8 from $32 after the company's phase 3 trial of OTIVIDEX in Meniere's missed its primary endpoint and didn't show an impact on any secondary endpoints. Duncan, who sees the news dealing a "clear credibility hit" to Otonomy, added that the "slow-going" launch of OTIPRIO is now perhaps the main value driver of the stock in the near-term.
08/31/17
RHCO
08/31/17
NO CHANGE
RHCO
Otonomy price target lowered to $15 from $45 at SunTrust
SunTrust analyst Edward Nash cut his price target on Otonomy after the company's Meniere's treatment failed to meet its endpoints and the company discontinued the program. Nash says that the stock is undervalued at current levels and he keeps a Buy rating on the shares.
03/12/18
PIPR
03/12/18
UPGRADE
Target $11
PIPR
Overweight
Otonomy upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Charles Duncan upgraded Otonomy to Overweight and raised his price target for the shares to $11 from $8. The analyst believes the company has sufficient cash and a "clearly articulated" Phase 3 plan. He also believes little value is being accorded to Otividex's potential.
03/19/18
JPMS
03/19/18
DOWNGRADE
JPMS
Underweight
Otonomy downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama downgraded Otonomy to Underweight without a price target. The analyst sees "no true value drivers in 2018" with an additional third Phase 3 trial for Otividex in Meniere's disease needed for approval.

TODAY'S FREE FLY STORIES

CUK

Carnival plc

$52.15

-3.54 (-6.36%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Carnival plc falls -6.2% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

DWT

Britannia Bulk

$6.68

-0.46 (-6.44%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Britannia Bulk falls -6.5% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.58

-3.26 (-7.27%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -7.3% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$26.39

1.91 (7.80%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
California Resources rises 7.2% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

BBBY

Bed Bath & Beyond

$17.82

3.95 (28.48%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Options
Active trading in Bed, Bath and Beyond options as shares rally »

Active trading in Bed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

KEG

Key Energy

$4.48

0.59 (15.17%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
Key Energy rises 15.7% »

Key Energy is up 15.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

IO

ION Geophysical

$13.84

0.25 (1.84%)

10:00
03/26/19
03/26
10:00
03/26/19
10:00
Hot Stocks
ION Geophysical rises 7.7% »

ION Geophysical is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$137.77

1.13 (0.83%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Hot Stocks
Janssen submits sBLA for daratumumab combination therapy to FDA »

Janssen Pharmaceutical of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 25

    Apr

WAB

Wabtec

$70.62

0.62 (0.89%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Wabtec put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

, DO

Diamond Offshore

$10.69

0.39 (3.79%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Early notable gainers among liquid option names on March 26th »

Notable gainers among…

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

DO

Diamond Offshore

$10.69

0.39 (3.79%)

VIAB

Viacom

$27.08

0.75 (2.85%)

RIG

Transocean

$9.27

0.44 (4.98%)

NVDA

Nvidia

$181.50

7.695 (4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

DWDP

DowDuPont

$53.96

0.7 (1.31%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Conference/Events
House Science, Space & Technology to hold a hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 28

    May

09:51
03/26/19
03/26
09:51
03/26/19
09:51
Conference/Events
House Financial Services Committee to hold a markup »

The Committee holds a…

09:50
03/26/19
03/26
09:50
03/26/19
09:50
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

SQ

Square

$74.65

0.12 (0.16%)

09:49
03/26/19
03/26
09:49
03/26/19
09:49
Recommendations
Square analyst commentary  »

Opposition to Square ILC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

, GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Periodicals
Google's Local Experiments Project looks to bolster community news, Axios says »

Google (GOOG, GOOGL) is…

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

MNI

McClatchy

$5.01

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.92

-2.92 (-6.51%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.5% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$6.70

-0.44 (-6.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Britannia Bulk falls -6.4% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$51.67

-4.02 (-7.22%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Carnival plc falls -6.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

BBW

Build-A-Bear

$5.86

0.22 (3.90%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Build-A-Bear rises 4.1% »

Build-A-Bear is up 4.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCO

Universal Compression

$21.55

0.86 (4.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Universal Compression rises 4.2% »

Universal Compression is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$25.64

1.16 (4.74%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
California Resources rises 4.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

March Consumer Confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

March Richmond Fed…

MDSO

Medidata

$75.89

(0.00%)

09:44
03/26/19
03/26
09:44
03/26/19
09:44
Hot Stocks
Breaking Hot Stocks news story on Medidata »

Medidata mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.